Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 651,000 | N/A | N/A | N/A |
| Receivables | 258,000 | N/A | N/A | N/A |
| Inventories | 194,000 | N/A | N/A | N/A |
| Income taxes - deferred | 93,000 | N/A | N/A | N/A |
| Other current assets | 793,000 | 0 | 0 | 0 |
| TOTAL | $1,989,000 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 4,951,000 | N/A | N/A | N/A |
| Intangibles | 347,000 | 0 | 0 | 0 |
| Other Non-Current Assets | 250,000 | 0 | 0 | 0 |
| TOTAL | $5,548,000 | $0 | $0 | $0 |
| Total Assets | $7,537,000 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 172,000 | 0 | 0 | 0 |
| Accrued Expenses | 297,000 | N/A | N/A | N/A |
| TOTAL | $1,166,000 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 3,190,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 445,000 | 0 | 0 | 0 |
| TOTAL | $4,104,000 | $N/A | $N/A | $N/A |
| Total Liabilities | $5,270,000 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 4,373,000 | N/A | N/A | N/A |
| Retained earnings | -2,135,000 | N/A | N/A | N/A |
| Other shareholders' equity | 59,000 | 0 | 0 | 0 |
| TOTAL | $2,267,000 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $7,537,000 | $0 | $0 | $0 |